Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymic malignancies.

P J Loehrer1, M R Wick

  • 1Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Cancer Treatment and Research
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Thymomas and thymic carcinomas, rare anterior mediastinum tumors, exhibit chemosensitivity. Further research into their molecular and immunologic aspects is crucial for future investigations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts.

Journal of cancer policy·2023
Same author

A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.

BMC infectious diseases·2019
Same author

Building cancer nursing skills in a resource-constrained government hospital.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2012
Same author

A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer.

Urologic oncology·2011
Same author

HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.

British journal of cancer·2005
Same author

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Area of Science:

  • Oncology
  • Immunology
  • Thoracic Surgery

Background:

  • Thymomas and thymic carcinomas are rare tumors originating in the anterior mediastinum.
  • These neoplasms are associated with various paraneoplastic syndromes, attracting significant clinical interest.
  • Recent findings indicate that thymomas possess chemosensitive properties.

Purpose of the Study:

  • To summarize the current understanding of thymomas and thymic carcinomas.
  • To highlight the chemosensitive nature of thymomas.
  • To identify areas for future research, including molecular and immunologic aspects.

Main Methods:

  • Review of existing literature on thymomas and thymic carcinomas.
  • Analysis of data regarding the chemosensitivity of these tumors.

Related Experiment Videos

  • Identification of knowledge gaps in molecular and immunological understanding.

    • Main Results:

    • Thymomas and thymic carcinomas are distinct anterior mediastinal tumors.
    • Chemosensitivity has been demonstrated in thymomas.
    • The indolent and rare nature of these tumors complicates clinical trial evaluation.

    Conclusions:

    • Thymomas are chemosensitive neoplasms.
    • Prospective randomized clinical trials for these rare tumors are challenging.
    • Future research should focus on the molecular and immunological characteristics of thymomas and thymic carcinomas.